These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38100282)

  • 1. Analysis of the yearly transition function in measles disease modeling.
    Davila-Payan CS; Hill A; Kayembe L; Alexander JP; Lynch M; Pallas SW
    Stat Med; 2024 Feb; 43(3):435-451. PubMed ID: 38100282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles, mumps, rubella prevention: how can we do better?
    Kauffmann F; Heffernan C; Meurice F; Ota MOC; Vetter V; Casabona G
    Expert Rev Vaccines; 2021 Jul; 20(7):811-826. PubMed ID: 34096442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integer-valued functional data analysis for measles forecasting.
    Kowal DR
    Biometrics; 2019 Dec; 75(4):1321-1333. PubMed ID: 31254384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles: summary of worldwide impact.
    Assaad F
    Rev Infect Dis; 1983; 5(3):452-9. PubMed ID: 6878998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Measles control in developing countries].
    Cutts FT; Dabis F
    Sante; 1994; 4(3):163-71. PubMed ID: 7921681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact on Epidemic Measles of Vaccination Campaigns Triggered by Disease Outbreaks or Serosurveys: A Modeling Study.
    Lessler J; Metcalf CJ; Cutts FT; Grenfell BT
    PLoS Med; 2016 Oct; 13(10):e1002144. PubMed ID: 27727285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of local vaccine coverage and recent incidence on measles transmission in France between 2009 and 2018.
    Robert A; Kucharski AJ; Funk S
    BMC Med; 2022 Mar; 20(1):77. PubMed ID: 35264161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protecting the vaccinating population in the face of a measles epidemic: assessing the impact of adjusted vaccination schedules.
    van den Hof S; Wallinga J; Widdowson MA; Conyn-van Spaendonck MA
    Epidemiol Infect; 2002 Feb; 128(1):47-57. PubMed ID: 11895090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospects for the eradication of infectious diseases.
    Stuart-Harris C
    Rev Infect Dis; 1984; 6(3):405-11. PubMed ID: 6377445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Vaccine Refusal and Vaccine-Preventable Diseases in the United States: A Review of Measles and Pertussis.
    Phadke VK; Bednarczyk RA; Salmon DA; Omer SB
    JAMA; 2016 Mar; 315(11):1149-58. PubMed ID: 26978210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles incidence in South Africa: a six-year review, 2015-2020.
    Yousif M; Hong H; Malfeld S; Smit S; Makhathini L; Motsamai T; Tselana D; Manamela M; Kamupira M; Maseti E; Ranchod H; Otwombe K; McCarthy K; Suchard M
    BMC Public Health; 2022 Aug; 22(1):1647. PubMed ID: 36042453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measles outbreak risk in Pakistan: exploring the potential of combining vaccination coverage and incidence data with novel data-streams to strengthen control.
    Wesolowski A; Winter A; Tatem AJ; Qureshi T; Engø-Monsen K; Buckee CO; Cummings DAT; Metcalf CJE
    Epidemiol Infect; 2018 Sep; 146(12):1575-1583. PubMed ID: 29860954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles eradication: recommendations from a meeting cosponsored by the World Health Organization, the Pan American Health Organization, and CDC.
    MMWR Recomm Rep; 1997 Jun; 46(RR-11):1-20. PubMed ID: 9213745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of measles and rubella vaccination programmes for disease elimination: a modelling study.
    Winter AK; Lambert B; Klein D; Klepac P; Papadopoulos T; Truelove S; Burgess C; Santos H; Knapp JK; Reef SE; Kayembe LK; Shendale S; Kretsinger K; Lessler J; Vynnycky E; McCarthy K; Ferrari M; Jit M
    Lancet Glob Health; 2022 Oct; 10(10):e1412-e1422. PubMed ID: 36113527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles epidemic in Romania, 1996-1998: assessment of vaccine effectiveness by case-control and cohort studies.
    Hennessey KA; Ion-Nedelcu N; Craciun MD; Toma F; Wattigney W; Strebel PM
    Am J Epidemiol; 1999 Dec; 150(11):1250-7. PubMed ID: 10588086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards eradication of measles virus: global progress and strategy evaluation.
    Nokes DJ; Williams JR; Butler AR
    Vet Microbiol; 1995 May; 44(2-4):333-50. PubMed ID: 8588328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introducing a novel model to estimate national and global measles disease burden.
    Miller MA
    Int J Infect Dis; 2000; 4(1):14-20. PubMed ID: 10689209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling transmission dynamics of measles in Nepal and its control with monitored vaccination program.
    Pokharel A; Adhikari K; Gautam R; Uprety KN; Vaidya NK
    Math Biosci Eng; 2022 Jun; 19(8):8554-8579. PubMed ID: 35801477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.